Dr Reddy’s Laboratories enters into licensing agreement with Slayback Pharma
The partnership aims to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify in the US
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
licensing agreement
Cambrian Biopharma announces licensing agreement to develop selective mTOR inhibitors
mTOR inhibitors prevent age-related physiologic decline and lengthen healthspan
Boehringer Ingelheim, Enara Bio sign pact to discover novel shared antigens for cancer…
Collaboration focuses on up to three types of lung and gastrointestinal (GI) cancers
Cipla signs licensing pact with MultiG for COVID-19 rapid antibody test kit
'Covi-G' has been commercialised in 20+ countries, with sensitivity and specificity exceeding 92 per cent, informs company
Vor Biopharma signs exclusive license pact with NCI for clinical-stage CD33 CAR-T
It is currently being evaluated in a multi-site Phase 1/2 clinical trial in children and young adults with relapsed or refractory…
Dr Reddy’s signs agreement with FUJIFILM and Global Response Aid for Avigan (favipiravir)
Dr Reddy’s would have exclusive rights for development, selling and distribution of Avigan in India.
Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir
Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up…
Zydus Cadila inks licensing pact with Gilead for remdesivir
The licence is royalty-free until another pharma product or vaccine is approved for the treatment or prevention of COVID-19 by the…
SPARC and Sun Pharma enter into license agreement for SCD-044
It is a potential treatment for atopic dermatitis, psoriasis and other auto-immune disorders